Original Investigation
Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis For Up to 3 Years: An Open-Label Extension of Randomized Clinical Trials
April W. Armstrong, MD, MPH; Mark Lebwohl, MD; Richard B. Warren, MBChB (Hons), PhD; et al.
Merkel Cell Carcinoma and Immunosuppression, UV Radiation, and Merkel Cell Polyomavirus
Jacob T. Tribble, BA; Ruth M. Pfeiffer, PhD; Isaac Brownell, MD, PhD; et al.
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial
Sonja Ständer, MD; Gil Yosipovitch, MD; Franz J. Legat, MD; et al.
Images in Dermatology
Pili Annulati
Emel Öztürk Durmaz, MD
Earn CME credit
Research Letter
Ultraprocessed Food Intake and Psoriasis
Laetitia Penso, PhD; Mathilde Touvier, PhD; Bernard Srour, PharmD, MPH, PhD; et al.
Observation
Wood Lamp as a Possible Helpful Diagnostic Tool to Detect Cutaneous Diphtheria
Matiar Madanchi, MD; Riccardo Curatolo, MD; Alexander A. Navarini, MD, PhD; et al.
From JAMA This Week
MD-Granting Medical Schools in the US, 2023-2024
Barbara Barzansky, PhD; Felicia Walker
Graduate Medical Education, 2023-2024
John S. Andrews, MD; Chris Mathews, BA
Gap Years—Unbridled Good or Unwarranted Cost?
Richard M. Schwartzstein, MD; Sammer Marzouk, MA
Medical Education’s Learning Opportunity
Atul Grover, MD, PhD
|